Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 1,676–1,700 of 7,816 matching trials · page 68 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
UPenn Observational Research Repository on Neurodegenerative Disease NCT04715399 No intervention Runs in: United States · 1 site |
NA other |
RECRUITING | 1,000 | University of Pennsylvania OTHER |
2026-01-22 |
|
Collaborative Care Coordination Program for Alzheimer's Disease and Related Dementias NCT05281744 Dementia Care Consultation program Runs in: United States · 1 site |
NA other |
COMPLETED | 2,160 | Harvard Pilgrim Health Care OTHER |
2026-01-22 |
|
Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for Mild Cognitive Impairment or Mild Alzheimer's Disease Undergoing Standard of Care Monoclonal Antibody (mAb) Therapy NCT05469009 Aducanumab; Exablate Model 4000 Type 2; Lecanemab Runs in: United States · 1 site |
EARLY_PHASE1 anti-amyloid-antibody |
ACTIVE_NOT_RECRUITING | 15 | Ali Rezai OTHER |
2026-01-22 |
|
Neurocognitive Assessment Platform 4 Alzheimer NCT07272811 Runs in: Italy · 1 site |
NA other |
RECRUITING | 100 | IRCCS San Raffaele OTHER |
2026-01-22 |
|
Mild Cognitive Impairment and Psychopathology NCT07358962 Runs in: Italy · 1 site |
NA other |
NOT_YET_RECRUITING | 118 | IRCCS Centro Neurolesi Bonino Pulejo OTHER |
2026-01-22 |
|
Erythrocyte Complement Receptor 1 and Alzheimer Disease NCT01565434 CR1 impact Runs in: France · 1 site |
NA other |
COMPLETED | 200 | CHU de Reims OTHER |
2026-01-21 |
|
Amyloid Beta-peptide 1-40 and Alzheimer's Disease NCT02770482 spinal fluid collection Runs in: France · 1 site |
NA other |
COMPLETED | 204 | CHU de Reims OTHER |
2026-01-21 |
|
ExAblate Blood-Brain Barrier Opening for Treatment of Alzheimer's Disease NCT03739905 Blood Brain Barrier (BBB) Disruption Runs in: Canada · 1 site |
NA other |
COMPLETED | 35 | InSightec INDUSTRY |
2026-01-21 |
|
SleepSMART for Veterans With MCI and Insomnia NCT05016960 Sleep-SMART Runs in: United States · 1 site |
NA other |
COMPLETED | 30 | VA Office of Research and Development OTHER_GOV |
2026-01-21 |
|
A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3) NCT05026866 Donanemab; Placebo Runs in: Japan; Puerto Rico; United States · 216 sites |
PHASE3 anti-amyloid-antibody |
ACTIVE_NOT_RECRUITING | 2,996 | Eli Lilly and Company INDUSTRY |
2026-01-21 |
|
A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes NCT05956834 PAMSys; LEGSys Runs in: United States · 2 sites |
NA other |
ACTIVE_NOT_RECRUITING | 60 | Massachusetts General Hospital OTHER |
2026-01-21 |
|
Continuation Study for Latozinemab NCT06111014 Latozinemab Runs in: Belgium; Canada; France; Germany; Italy; Netherlands; Por... · 18 sites |
PHASE3 other |
TERMINATED | 17 | Alector Inc. INDUSTRY |
2026-01-21 |
|
Cognitive Health in Ageing Register: Investigational and Observational Trial Studies in Dementia Research (CHARIOT): Prospective Readiness Cohort (PRO) Longitudinal Study NCT06953167 Runs in: United Kingdom · 1 site |
NA other |
RECRUITING | 600 | Imperial College London OTHER |
2026-01-21 |
|
CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial NCT06983769 MAD; CPAP Runs in: Singapore · 1 site |
NA other |
RECRUITING | 260 | National University Hospital, Singapore OTHER |
2026-01-21 |
|
Effectiveness of the Safe Haven Application (App) Among Undergraduates NCT07340983 Safe Haven App Runs in: Taiwan · 1 site |
NA other |
RECRUITING | 68 | National Cheng-Kung University Hospital OTHER |
2026-01-21 |
|
Ultrasound-Guided Stellate Ganglion Block for Alzheimer's Disease NCT07351773 Ultrasound-Guided Stellate Ganglion Block; Memantine hydrochloride;... Runs in: China · 1 site |
NA symptomatic-cholinergic |
COMPLETED | 40 | Taizhou Second People's Hospital OTHER |
2026-01-21 |
|
Home Based Functional Balance Intervention for Multiple Sclerosis NCT07355387 Multicomponent balance intervention consisting of four components i... Runs in: United States · 1 site |
NA other |
RECRUITING | 75 | University of Illinois at Chicago OTHER |
2026-01-21 |
|
DemTool - Supporting Life With Dementia NCT07355829 Life with dementia in the community - Support group for family care... Runs in: Denmark · 1 site |
NA other |
COMPLETED | 272 | Danish Dementia Research Centre NETWORK |
2026-01-21 |
|
Cardiovascular Risk Assessment in Young Women After Index Pregnancy With and Without Placental Complications NCT07356817 Runs in: Spain · 1 site |
NA other |
RECRUITING | 1,260 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau OTHER |
2026-01-21 |
|
Comprehensive Assessment of Neurodegeneration and Dementia NCT03402919 Runs in: Canada · 19 sites |
NA other |
RECRUITING | 1,573 | McGill University OTHER |
2026-01-20 |
|
Make Better Choices 2 for Rural Appalachians NCT04309461 Stress Management Control; Adapted MBC2 Program Runs in: United States · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 279 | Nancy Schoenberg OTHER |
2026-01-20 |
|
Taiwan Associated Genetic and Nongenetic Small Vessel Disease NCT05473637 MRI Runs in: Taiwan · 1 site |
NA other |
RECRUITING | 500 | National Taiwan University Hospital OTHER |
2026-01-20 |
|
Evaluating the Feasibility of elleFA App Implementation NCT06452407 Implementation of elleFA smartphone application Runs in: Canada · 1 site |
NA other |
RECRUITING | 20 | McGill University Health Centre/Research Institute of the McGill University Health Centre OTHER |
2026-01-20 |
|
Effect of Intranasal Negative Pressure Therapy on Cognitive Function in Patients With Mild Cognitive Impairment and Obstructive Sleep Apnea NCT07353359 Intranasal Negative Pressure Runs in: China · 1 site |
NA other |
NOT_YET_RECRUITING | 65 | Xuanwu Hospital, Beijing OTHER |
2026-01-20 |
|
miR-342-5p/AnkG Pathway in Early AD Synaptic Dysfunction NCT07353502 Collect peripheral blood, and if the patient consents, also collect... Runs in: China · 1 site |
NA other |
RECRUITING | 40 | The Fourth Affiliated Hospital of Zhejiang University School of Medicine OTHER |
2026-01-20 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial